Connect with us

BUSINESS

Valens Company Inc (OTCMKTS: VLNCF) Announces the Acquisition of Verse Cannabis and creates a Top tier Canadian Licensed Producer

Published

on

A leading manufacturer of medical cannabis products, Valens Company Inc (OTCMKTS: VLNCF), announced that it acquired Verse Cannabis by completing all transactions. Moreover, by this transaction, Valens Company acquires all of the Verse intellectual property. Along with that, Valens’ recent agreement with Citizen Stash to acquire all of the outstanding shares positions Valens as top row cannabis licensed manufacturer in the Canadian industry.

The Verse has appeared as a leading cannabis brand since its launch in August 2020, with a broadening portfolio that extends all major categories. By starting with its tropic lemon 510 vape cartridges and with the recent launch of BC god bud 28g, Verse proves itself as a settler in the value segment. In addition, Verse boasts various enhancing products in its portfolios, such as baked apple soft chews, sour medley, chocolate brownie, rapid tropical beverage, and THC. Moreover, Verse provides high-quality products to consumers with a range of cannabis consumptions without the high price point.

Tyler Robson’s Statement

Chief Executive Officer of Valens Company, and Chair of the Board, Tyler Robson, commented that Valens anticipates becoming an ally to both consumer and customer. By this acquisition of both Citizen Stash and Verse, Valens fulfilled their desire. He also adds that they believe in making the best products for consumers they deserve on the right path without cutting corners. Valens is continuing purity in extraction, formulation, development to offer the benefits of cannabis to all sets of consumers in the world, whether it is recreational or medical or local or global, or Valens owned brands. Moreover, the expanded platform at Valens will better serve current and future consumers and customers through innovative product offerings at reasonable pricing points while increasing shareholder value through their branded products.

Furthermore, with the acquisition of Citizen stash and Verse, Valens is currently well-positioned to drive share gains, close the valuation gap and maximize the shareholders’ value. Valens’s strategic highlights include enhancing brand portfolio with a leading value brand, accretive transaction, existing Valens’ products portfolio with a pipeline ripe for expansion, and becoming an ally to consumers and customers.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

BUSINESS

VIVO Cannabis Inc Provides Strategic Update Regarding Company’s Future and for Medical

Published

on

A leading provider of premium medical cannabis and services, VIVO Cannabis Inc, (OTCMKTS: VVCIF) announced the strategic updates regarding its future for its shareholders on August 25. In addition, the wholly-owned license holder of Canna Farms and ABcann Medicals subsidiaries provides additional information regarding the company’s focus after July 5, 2021. In the previous reports, VIVO Cannabis elected a new slate of Board Directors. Also, it announced the new Chief

Executive Officer, Ray Laflamme, and since that, the company’s Board and Management reviving its business strategy actively.

VIVO Cannabis’ board of directors met to review the company’s proposed strategy. In addition, it also assessed alternative options and announced that it would enhance its focus on assisting its medical business retail, health, and wellness. Moreover, currently, the company is positioned as strong in medical cannabis by having many assets. By enhancing these assets, the company anticipates establishing itself as an international medical leader focused on improving the patients’ lives.

VIVO Path to Profitability

VIVO Cannabis targets feedback from its medical stakeholders and patients, reduces operations expenses, and integrates its business and operating systems to attain profitability. VIVO

Cannabis’s Strong assets are Canna Farms and ABcann Medicinals, EU-GMP Certification, Harvest Medicine, Patient care expertise, Germany, Australia, and other international markets.

Ray Laflamme’s Statement

Chief Executive Officer, Ray Laflamme, said they recognized their strengths and are committed to providing value to their patients and shareholders by improving those strengths. He also adds that they will continue to work as a team and listen to the patient’s needs, health professionals, advocacy, and payors groups in domestic and global medical markets. With an enhanced and renewed focus on their medical channels’ core values, VIVO Cannabis re-commit to assisting people as their top priority.

Canna Farms began as a first patient company from the beginning. This is a progression to re-commit their efforts given their success in the last six years. The company expects to maintain recreational sales on core products to support consumers who purchase across these channels in health and wellness products.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Endexx’s Subsidiary, Go Green Global, Initiates the Launch of its Herb House dispensary in Jamaica

Published

on

A leading provider of Hemp, nutritional, and wellness products, Endexx Corporation announced that its international subsidiary, Go Green Global, initiated a soft launch of ‘Herb House’ in Ocho Rios, Jamaica. Endexx Corporation announced the initiative on August 23 by enabling the first Go Green Global’s licensed store to carry premium marijuana for medical purchase and other related superior products for the consumers. Go Green launched the herb house in the Taj Mahal shopping center in Ocho Rios, one of the famous tourist destinations that also enables consumers to enjoy shopping. Moreover, the shop is well placed at last to assist consumers before they depart for their tourist attractions to Ocho Rios waterfalls.

Todd Davis’s Comments

Chairman and Chief Executive Officer of Endexx, Mr. Todd Davis, commented that they are excited to officially start a business in Jamaica and increase the growth phase of global market revenue. Also, they believe that initiating the foundation for global markets; Jamaica is the perfect place to develop a primary international brand. In addition, Endexx Corporation continued its research to create innovative products and anticipate reaching the consumers broader. Moreover, they are more confident in achieving significant growth in revenue in their new business initiatives in the international cannabis industry.

Go Green Global offers many growth opportunities by adding more wholesale channels and distribution for their global customers. According to the Davis comments, their mission is to reach millions of customers with their medical and scientific approach, which they initiate their new venture into the global marketplace. Furthermore, Davis concluded that after three years of working with the CLS, since filed for the licenses in 2018, the accomplishment is significant for a global initiative.

Furthermore, Carnival Line docked on August 16, 2021, at the Ocho Rios port. The Carnival cruise is referred to as the first global cruise to visit Jamaica after 2019. Other premium lines are planning to re-enter the ports of Jamaica in the Caribbean waters. This is the initiative of tourism to Jamaica.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Planet 13 Holdings Inc (OTCMKTS: PLNHF) Announces Divestiture of Florida License with Harvest Health

Published

on

Harvest Health & Recreation Inc (OTCMKTS: HRVSF), is a multi-state operator in the United States, recently announced that it had signed a definitive divestiture agreement with Planet 13 Holdings Inc (OTCMKTS: PLNHF) for its Medical-Grade Cannabis Treatment license from Florida’s Department of Health.

Planet 13 Holdings Inc (OTCMKTS: PLNHF) has agreed to buy the license for approximately $55 million. The planned divestitures are made up of the license sale only and don’t include any operational or planned facilities. Closing this specific divestiture remains subject to the CSCC (customary satisfaction of closing conditions), including the planned acquisition of Trulieve Cannabis Corp and other regulatory approvals

Senior Management

Steve White, the company’s Chief Executive Officer, said that they’re delighted to have entered into this divestiture agreement for the Florida license, which they’ll need if they want to finalize the Trulieve deal. He further stated that they’re encouraged by how much progress they’ve made so far and will continue to strive and complete both deals. Harvest’s financial adviser in this deal was Canaccord Genuity Corporation.

Harvest Health has its headquarters in Tempe, Arizona. It’s a multi-state operator and a vertically integrated cannabis corporation. Since 2011, the company has been dedicated to expanding its wholesale and retail footprint all across the United States. The company is dedicated to selling, manufacturing, and acquiring cannabis-based products for both consumers and patients all across the country. In addition to all this, the company also wants to provide dispensaries with their services. Through targeted acquisitions, service agreements, and organic license wins, Harvest Health has created operational footprints spanning many different states in the United States.  

Todd Harrison posted on Twitter about this deal and even mentioned the consideration price of $55 million. Many people had mixed reactions about the whole transaction, but a majority felt like both parties were getting one step closer to achieving the business goals they set out when they started doing what they do now.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories